The US Food and Drug Administration (FDA) has granted clearance to icotec for the use of its BlackArmor implants in treating de novo spinal infections. This is claimed to make icotec the first and ...
icotec is honored to be the first and only company in the United States with FDA 510(k) clearance for stabilizing the spine in de novo spinal infections, including discitis, osteomyelitis ...
icotec, a leading company for the treatment of spinal tumours and spinal infections, announced that it has received FDA clearance for the use of BlackArmor implants in the treatment of de novo spinal ...
EAST HARTFORD, Conn., Jan. 14, 2025 /PRNewswire/ -- icotec is proud to announce that it has received FDA clearance for the use of BlackArmor® implants in the treatment of de novo spinal infections.
EAST HARTFORD, Conn., Jan. 14, 2025 /PRNewswire/ -- icotec is proud to announce that it has received FDA clearance for the use of BlackArmor® implants in the treatment of de novo spinal infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results